Načítá se...
Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis
BACKGROUND: Treatment with tumor necrosis factor inhibitors for rheumatoid arthritis has been associated with a decreased risk of cardiovascular disease in observational studies. There are conflicting data on the influence of tumor necrosis factor inhibitors on lipid levels. OBJECTIVES: To evaluate...
Uloženo v:
| Vydáno v: | Curr Ther Res Clin Exp |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097545/ https://ncbi.nlm.nih.gov/pubmed/30128057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2018.07.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|